Review



rabbit anti crth2 dp2  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    OriGene rabbit anti crth2 dp2
    Rabbit Anti Crth2 Dp2, supplied by OriGene, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+crth2+antibody/pmc04954606__NIHMS69115___supplement___supplemental_data-142-4-8
    Average 86 stars, based on 1 article reviews
    rabbit anti crth2 dp2 - by Bioz Stars, 2026-11
    86/100 stars

    Images

    Related Articles

    other:

    Article Title: Eosinophils contribute to intestinal inflammation via chemoattractant receptor-homologous molecule expressed on Th2 cells, CRTH2, in experimental Crohn’s disease
    Article Snippet: For separation and detection of protein, SDS-PAGE (Life Technologies, Invitrogen, Vienna, Austria) was performed and gels were blotted onto polyvinylidene difluoride (PVDF) membranes (Merck Millipore, Billerica, MA, USA).

    Incubation:

    Article Title: Eosinophils contribute to intestinal inflammation via chemoattractant receptor-homologous molecule expressed on Th2 cells, CRTH2, in experimental Crohn’s disease
    Article Snippet: For separation and detection of protein, SDS-PAGE (Life Technologies, Invitrogen, Vienna, Austria) was performed and gels were blotted onto polyvinylidene difluoride (PVDF) membranes (Merck Millipore, Billerica, MA, USA). .. Membranes were blocked in TBS-tween buffer containing 5% milk powder and subsequently incubated with rabbit anti-CRTH2 antibody (1:1000; Acris Antibodies, Herford, Germany), and mouse anti-β-actin antibodies (Sigma, St. Louis, MO, USA) overnight at 4°C. .. Membranes were washed and incubated with HRP-conjugated anti-rabbit antibodies (1:7500; Jackson ImmunoResearch Laboratories, West Grove, PA, USA) for 1 h at room temperature.



    Similar Products

    94
    Bioss rabbit anti human crth2 polyclonal antibody
    Rabbit Anti Human Crth2 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+crth2+antibody/GPR44+Polyclonal+Antibody/pm40445384-105-3-9
    Average 94 stars, based on 1 article reviews
    rabbit anti human crth2 polyclonal antibody - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Alomone Labs rabbit anti dopamine d2r extracellular receptor
    Rabbit Anti Dopamine D2r Extracellular Receptor, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+crth2+antibody/Anti-CRTH2%2FGPR44+Antibody/pm39937830-82-29-34
    Average 94 stars, based on 1 article reviews
    rabbit anti dopamine d2r extracellular receptor - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    92
    ProSci Incorporated rabbit raised anti crth2
    Rabbit Raised Anti Crth2, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+crth2+antibody/CRTH2+Antibody/pm38391908-85-7-9
    Average 92 stars, based on 1 article reviews
    rabbit raised anti crth2 - by Bioz Stars, 2026-11
    92/100 stars
      Buy from Supplier

    90
    Thermo Fisher rabbit anti-crth2
    ( A ) Summary of CHI3L1 receptors and downstream signaling pathways. ( B ) Expression of <t>CRTH2</t> receptor in NSCs (GFAP + Sox2 + ) but not immature (DCX + ) or mature (NeuN + ) neurons in adult hippocampus. Scale bars, 20 μm. ( C ) CRTH2 expression in cultured NSCs (Sox2 + Nestin + ). ( D ) Activation of GSK-3β (reduced inhibitory serine-9 phosphorylation) and inhibition of β-catenin (increased degradation) in NSC cultures treated with CHI3L1 (100 ng/ml). n = 3. ( E ) Lentiviral vectors to express two shRNAs for CRTH2 knockdown (Lenti-shCRTH2, shCRTH2_1, and shCRTH2_2) and a control shRNA (Lenti-shNC). ( F ) shRNA-mediated CRTH2 knockdown efficiency. n = 3. ( G ) CRTH2 knockdown effect on GSK-3β/β-catenin pathway activation by CHI3L1 (2-hour treatment). n = 3. ( H ) CRTH2 knockdown effect on NSC proliferation in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( I ) CRTH2 knockdown effect on NSC differentiation into neurons (Tuj1 + ) and glia (GFAP + ) in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( J ) Identified CHI3L1 signaling pathway inhibitory to neurogenesis: CHI3L1 binds to CRTH2 receptor and activates GSK-3β that in turn phosphorylates and destabilizes β-catenin and leads to reduced transcriptional activities for neurogenesis. ( K ) Timeline for assays of NSC proliferation and neuronal differentiation in msCtrl-IgG– or msAQP4-IgG–injected mice, receiving a potent GSK-3β inhibitor, TWS119 (30 mg/kg), intraperitoneally daily for 3 weeks. ( L to N ) Quantification of total proliferating cells (EdU + ), radial glia–like NSCs (EdU + GFAP + ), and transiently amplifying progenitor-like (EdU + GFAP − ) cells. n = 4. ( O to Q ) Quantification of proliferating cells (BrdU + ) at the time of hsAQP4-IgG injection, newborn immature neurons (BrdU + DCX + ), and mature neurons (BrdU + NeuN + ). n = 4. All bar graphs presented in means ± SEM and analyzed by one-way ANOVA and Tukey’s post hoc analyses. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    Rabbit Anti Crth2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+crth2+antibody/pmc10530095-302-60-63
    Average 90 stars, based on 1 article reviews
    rabbit anti-crth2 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Novus Biologicals rabbit anti-human crth2 (gpr44
    ( A ) Summary of CHI3L1 receptors and downstream signaling pathways. ( B ) Expression of <t>CRTH2</t> receptor in NSCs (GFAP + Sox2 + ) but not immature (DCX + ) or mature (NeuN + ) neurons in adult hippocampus. Scale bars, 20 μm. ( C ) CRTH2 expression in cultured NSCs (Sox2 + Nestin + ). ( D ) Activation of GSK-3β (reduced inhibitory serine-9 phosphorylation) and inhibition of β-catenin (increased degradation) in NSC cultures treated with CHI3L1 (100 ng/ml). n = 3. ( E ) Lentiviral vectors to express two shRNAs for CRTH2 knockdown (Lenti-shCRTH2, shCRTH2_1, and shCRTH2_2) and a control shRNA (Lenti-shNC). ( F ) shRNA-mediated CRTH2 knockdown efficiency. n = 3. ( G ) CRTH2 knockdown effect on GSK-3β/β-catenin pathway activation by CHI3L1 (2-hour treatment). n = 3. ( H ) CRTH2 knockdown effect on NSC proliferation in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( I ) CRTH2 knockdown effect on NSC differentiation into neurons (Tuj1 + ) and glia (GFAP + ) in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( J ) Identified CHI3L1 signaling pathway inhibitory to neurogenesis: CHI3L1 binds to CRTH2 receptor and activates GSK-3β that in turn phosphorylates and destabilizes β-catenin and leads to reduced transcriptional activities for neurogenesis. ( K ) Timeline for assays of NSC proliferation and neuronal differentiation in msCtrl-IgG– or msAQP4-IgG–injected mice, receiving a potent GSK-3β inhibitor, TWS119 (30 mg/kg), intraperitoneally daily for 3 weeks. ( L to N ) Quantification of total proliferating cells (EdU + ), radial glia–like NSCs (EdU + GFAP + ), and transiently amplifying progenitor-like (EdU + GFAP − ) cells. n = 4. ( O to Q ) Quantification of proliferating cells (BrdU + ) at the time of hsAQP4-IgG injection, newborn immature neurons (BrdU + DCX + ), and mature neurons (BrdU + NeuN + ). n = 4. All bar graphs presented in means ± SEM and analyzed by one-way ANOVA and Tukey’s post hoc analyses. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    Rabbit Anti Human Crth2 (Gpr44, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+crth2+antibody/Rabbit+anti-Human+IgG+(H%2BL)+Secondary+Antibody/pmc08600612__annrheumdis___2020___219748supp001-80-17-22
    Average 90 stars, based on 1 article reviews
    rabbit anti-human crth2 (gpr44 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Novus Biologicals rabbit anti-human crth2 (gpr44)
    ( A ) Summary of CHI3L1 receptors and downstream signaling pathways. ( B ) Expression of <t>CRTH2</t> receptor in NSCs (GFAP + Sox2 + ) but not immature (DCX + ) or mature (NeuN + ) neurons in adult hippocampus. Scale bars, 20 μm. ( C ) CRTH2 expression in cultured NSCs (Sox2 + Nestin + ). ( D ) Activation of GSK-3β (reduced inhibitory serine-9 phosphorylation) and inhibition of β-catenin (increased degradation) in NSC cultures treated with CHI3L1 (100 ng/ml). n = 3. ( E ) Lentiviral vectors to express two shRNAs for CRTH2 knockdown (Lenti-shCRTH2, shCRTH2_1, and shCRTH2_2) and a control shRNA (Lenti-shNC). ( F ) shRNA-mediated CRTH2 knockdown efficiency. n = 3. ( G ) CRTH2 knockdown effect on GSK-3β/β-catenin pathway activation by CHI3L1 (2-hour treatment). n = 3. ( H ) CRTH2 knockdown effect on NSC proliferation in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( I ) CRTH2 knockdown effect on NSC differentiation into neurons (Tuj1 + ) and glia (GFAP + ) in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( J ) Identified CHI3L1 signaling pathway inhibitory to neurogenesis: CHI3L1 binds to CRTH2 receptor and activates GSK-3β that in turn phosphorylates and destabilizes β-catenin and leads to reduced transcriptional activities for neurogenesis. ( K ) Timeline for assays of NSC proliferation and neuronal differentiation in msCtrl-IgG– or msAQP4-IgG–injected mice, receiving a potent GSK-3β inhibitor, TWS119 (30 mg/kg), intraperitoneally daily for 3 weeks. ( L to N ) Quantification of total proliferating cells (EdU + ), radial glia–like NSCs (EdU + GFAP + ), and transiently amplifying progenitor-like (EdU + GFAP − ) cells. n = 4. ( O to Q ) Quantification of proliferating cells (BrdU + ) at the time of hsAQP4-IgG injection, newborn immature neurons (BrdU + DCX + ), and mature neurons (BrdU + NeuN + ). n = 4. All bar graphs presented in means ± SEM and analyzed by one-way ANOVA and Tukey’s post hoc analyses. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    Rabbit Anti Human Crth2 (Gpr44), supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+crth2+antibody/rabbit+anti+human+crth2++gpr44/pmc08600612__annrheumdis___2020___219748supp001-80-16-22
    Average 90 stars, based on 1 article reviews
    rabbit anti-human crth2 (gpr44) - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    ProSci Incorporated rabbit anti crth2 ab (#4027)
    ( A ) Summary of CHI3L1 receptors and downstream signaling pathways. ( B ) Expression of <t>CRTH2</t> receptor in NSCs (GFAP + Sox2 + ) but not immature (DCX + ) or mature (NeuN + ) neurons in adult hippocampus. Scale bars, 20 μm. ( C ) CRTH2 expression in cultured NSCs (Sox2 + Nestin + ). ( D ) Activation of GSK-3β (reduced inhibitory serine-9 phosphorylation) and inhibition of β-catenin (increased degradation) in NSC cultures treated with CHI3L1 (100 ng/ml). n = 3. ( E ) Lentiviral vectors to express two shRNAs for CRTH2 knockdown (Lenti-shCRTH2, shCRTH2_1, and shCRTH2_2) and a control shRNA (Lenti-shNC). ( F ) shRNA-mediated CRTH2 knockdown efficiency. n = 3. ( G ) CRTH2 knockdown effect on GSK-3β/β-catenin pathway activation by CHI3L1 (2-hour treatment). n = 3. ( H ) CRTH2 knockdown effect on NSC proliferation in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( I ) CRTH2 knockdown effect on NSC differentiation into neurons (Tuj1 + ) and glia (GFAP + ) in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( J ) Identified CHI3L1 signaling pathway inhibitory to neurogenesis: CHI3L1 binds to CRTH2 receptor and activates GSK-3β that in turn phosphorylates and destabilizes β-catenin and leads to reduced transcriptional activities for neurogenesis. ( K ) Timeline for assays of NSC proliferation and neuronal differentiation in msCtrl-IgG– or msAQP4-IgG–injected mice, receiving a potent GSK-3β inhibitor, TWS119 (30 mg/kg), intraperitoneally daily for 3 weeks. ( L to N ) Quantification of total proliferating cells (EdU + ), radial glia–like NSCs (EdU + GFAP + ), and transiently amplifying progenitor-like (EdU + GFAP − ) cells. n = 4. ( O to Q ) Quantification of proliferating cells (BrdU + ) at the time of hsAQP4-IgG injection, newborn immature neurons (BrdU + DCX + ), and mature neurons (BrdU + NeuN + ). n = 4. All bar graphs presented in means ± SEM and analyzed by one-way ANOVA and Tukey’s post hoc analyses. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    Rabbit Anti Crth2 Ab (#4027), supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+crth2+antibody/anti+crth2+antibody/pm26995677-102-10-15
    Average 90 stars, based on 1 article reviews
    rabbit anti crth2 ab (#4027) - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Novus Biologicals rabbit anti-human dp 2 (crth2) receptor antibody
    ( A ) Summary of CHI3L1 receptors and downstream signaling pathways. ( B ) Expression of <t>CRTH2</t> receptor in NSCs (GFAP + Sox2 + ) but not immature (DCX + ) or mature (NeuN + ) neurons in adult hippocampus. Scale bars, 20 μm. ( C ) CRTH2 expression in cultured NSCs (Sox2 + Nestin + ). ( D ) Activation of GSK-3β (reduced inhibitory serine-9 phosphorylation) and inhibition of β-catenin (increased degradation) in NSC cultures treated with CHI3L1 (100 ng/ml). n = 3. ( E ) Lentiviral vectors to express two shRNAs for CRTH2 knockdown (Lenti-shCRTH2, shCRTH2_1, and shCRTH2_2) and a control shRNA (Lenti-shNC). ( F ) shRNA-mediated CRTH2 knockdown efficiency. n = 3. ( G ) CRTH2 knockdown effect on GSK-3β/β-catenin pathway activation by CHI3L1 (2-hour treatment). n = 3. ( H ) CRTH2 knockdown effect on NSC proliferation in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( I ) CRTH2 knockdown effect on NSC differentiation into neurons (Tuj1 + ) and glia (GFAP + ) in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( J ) Identified CHI3L1 signaling pathway inhibitory to neurogenesis: CHI3L1 binds to CRTH2 receptor and activates GSK-3β that in turn phosphorylates and destabilizes β-catenin and leads to reduced transcriptional activities for neurogenesis. ( K ) Timeline for assays of NSC proliferation and neuronal differentiation in msCtrl-IgG– or msAQP4-IgG–injected mice, receiving a potent GSK-3β inhibitor, TWS119 (30 mg/kg), intraperitoneally daily for 3 weeks. ( L to N ) Quantification of total proliferating cells (EdU + ), radial glia–like NSCs (EdU + GFAP + ), and transiently amplifying progenitor-like (EdU + GFAP − ) cells. n = 4. ( O to Q ) Quantification of proliferating cells (BrdU + ) at the time of hsAQP4-IgG injection, newborn immature neurons (BrdU + DCX + ), and mature neurons (BrdU + NeuN + ). n = 4. All bar graphs presented in means ± SEM and analyzed by one-way ANOVA and Tukey’s post hoc analyses. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    Rabbit Anti Human Dp 2 (Crth2) Receptor Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+crth2+antibody/rabbit+anti+human+crth2++gpr44/pmc05264142-73-18-27
    Average 90 stars, based on 1 article reviews
    rabbit anti-human dp 2 (crth2) receptor antibody - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    86
    OriGene rabbit anti crth2 dp2
    ( A ) Summary of CHI3L1 receptors and downstream signaling pathways. ( B ) Expression of <t>CRTH2</t> receptor in NSCs (GFAP + Sox2 + ) but not immature (DCX + ) or mature (NeuN + ) neurons in adult hippocampus. Scale bars, 20 μm. ( C ) CRTH2 expression in cultured NSCs (Sox2 + Nestin + ). ( D ) Activation of GSK-3β (reduced inhibitory serine-9 phosphorylation) and inhibition of β-catenin (increased degradation) in NSC cultures treated with CHI3L1 (100 ng/ml). n = 3. ( E ) Lentiviral vectors to express two shRNAs for CRTH2 knockdown (Lenti-shCRTH2, shCRTH2_1, and shCRTH2_2) and a control shRNA (Lenti-shNC). ( F ) shRNA-mediated CRTH2 knockdown efficiency. n = 3. ( G ) CRTH2 knockdown effect on GSK-3β/β-catenin pathway activation by CHI3L1 (2-hour treatment). n = 3. ( H ) CRTH2 knockdown effect on NSC proliferation in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( I ) CRTH2 knockdown effect on NSC differentiation into neurons (Tuj1 + ) and glia (GFAP + ) in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( J ) Identified CHI3L1 signaling pathway inhibitory to neurogenesis: CHI3L1 binds to CRTH2 receptor and activates GSK-3β that in turn phosphorylates and destabilizes β-catenin and leads to reduced transcriptional activities for neurogenesis. ( K ) Timeline for assays of NSC proliferation and neuronal differentiation in msCtrl-IgG– or msAQP4-IgG–injected mice, receiving a potent GSK-3β inhibitor, TWS119 (30 mg/kg), intraperitoneally daily for 3 weeks. ( L to N ) Quantification of total proliferating cells (EdU + ), radial glia–like NSCs (EdU + GFAP + ), and transiently amplifying progenitor-like (EdU + GFAP − ) cells. n = 4. ( O to Q ) Quantification of proliferating cells (BrdU + ) at the time of hsAQP4-IgG injection, newborn immature neurons (BrdU + DCX + ), and mature neurons (BrdU + NeuN + ). n = 4. All bar graphs presented in means ± SEM and analyzed by one-way ANOVA and Tukey’s post hoc analyses. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    Rabbit Anti Crth2 Dp2, supplied by OriGene, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+crth2+antibody/pmc04954606__NIHMS69115___supplement___supplemental_data-142-4-8
    Average 86 stars, based on 1 article reviews
    rabbit anti crth2 dp2 - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Summary of CHI3L1 receptors and downstream signaling pathways. ( B ) Expression of CRTH2 receptor in NSCs (GFAP + Sox2 + ) but not immature (DCX + ) or mature (NeuN + ) neurons in adult hippocampus. Scale bars, 20 μm. ( C ) CRTH2 expression in cultured NSCs (Sox2 + Nestin + ). ( D ) Activation of GSK-3β (reduced inhibitory serine-9 phosphorylation) and inhibition of β-catenin (increased degradation) in NSC cultures treated with CHI3L1 (100 ng/ml). n = 3. ( E ) Lentiviral vectors to express two shRNAs for CRTH2 knockdown (Lenti-shCRTH2, shCRTH2_1, and shCRTH2_2) and a control shRNA (Lenti-shNC). ( F ) shRNA-mediated CRTH2 knockdown efficiency. n = 3. ( G ) CRTH2 knockdown effect on GSK-3β/β-catenin pathway activation by CHI3L1 (2-hour treatment). n = 3. ( H ) CRTH2 knockdown effect on NSC proliferation in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( I ) CRTH2 knockdown effect on NSC differentiation into neurons (Tuj1 + ) and glia (GFAP + ) in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( J ) Identified CHI3L1 signaling pathway inhibitory to neurogenesis: CHI3L1 binds to CRTH2 receptor and activates GSK-3β that in turn phosphorylates and destabilizes β-catenin and leads to reduced transcriptional activities for neurogenesis. ( K ) Timeline for assays of NSC proliferation and neuronal differentiation in msCtrl-IgG– or msAQP4-IgG–injected mice, receiving a potent GSK-3β inhibitor, TWS119 (30 mg/kg), intraperitoneally daily for 3 weeks. ( L to N ) Quantification of total proliferating cells (EdU + ), radial glia–like NSCs (EdU + GFAP + ), and transiently amplifying progenitor-like (EdU + GFAP − ) cells. n = 4. ( O to Q ) Quantification of proliferating cells (BrdU + ) at the time of hsAQP4-IgG injection, newborn immature neurons (BrdU + DCX + ), and mature neurons (BrdU + NeuN + ). n = 4. All bar graphs presented in means ± SEM and analyzed by one-way ANOVA and Tukey’s post hoc analyses. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Journal: Science Advances

    Article Title: CHI3L1 signaling impairs hippocampal neurogenesis and cognitive function in autoimmune-mediated neuroinflammation

    doi: 10.1126/sciadv.adg8148

    Figure Lengend Snippet: ( A ) Summary of CHI3L1 receptors and downstream signaling pathways. ( B ) Expression of CRTH2 receptor in NSCs (GFAP + Sox2 + ) but not immature (DCX + ) or mature (NeuN + ) neurons in adult hippocampus. Scale bars, 20 μm. ( C ) CRTH2 expression in cultured NSCs (Sox2 + Nestin + ). ( D ) Activation of GSK-3β (reduced inhibitory serine-9 phosphorylation) and inhibition of β-catenin (increased degradation) in NSC cultures treated with CHI3L1 (100 ng/ml). n = 3. ( E ) Lentiviral vectors to express two shRNAs for CRTH2 knockdown (Lenti-shCRTH2, shCRTH2_1, and shCRTH2_2) and a control shRNA (Lenti-shNC). ( F ) shRNA-mediated CRTH2 knockdown efficiency. n = 3. ( G ) CRTH2 knockdown effect on GSK-3β/β-catenin pathway activation by CHI3L1 (2-hour treatment). n = 3. ( H ) CRTH2 knockdown effect on NSC proliferation in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( I ) CRTH2 knockdown effect on NSC differentiation into neurons (Tuj1 + ) and glia (GFAP + ) in shRNA-expressing cultures, with or without CHI3L1 for 3 days. n = 4. Scale bars, 100 μm. ( J ) Identified CHI3L1 signaling pathway inhibitory to neurogenesis: CHI3L1 binds to CRTH2 receptor and activates GSK-3β that in turn phosphorylates and destabilizes β-catenin and leads to reduced transcriptional activities for neurogenesis. ( K ) Timeline for assays of NSC proliferation and neuronal differentiation in msCtrl-IgG– or msAQP4-IgG–injected mice, receiving a potent GSK-3β inhibitor, TWS119 (30 mg/kg), intraperitoneally daily for 3 weeks. ( L to N ) Quantification of total proliferating cells (EdU + ), radial glia–like NSCs (EdU + GFAP + ), and transiently amplifying progenitor-like (EdU + GFAP − ) cells. n = 4. ( O to Q ) Quantification of proliferating cells (BrdU + ) at the time of hsAQP4-IgG injection, newborn immature neurons (BrdU + DCX + ), and mature neurons (BrdU + NeuN + ). n = 4. All bar graphs presented in means ± SEM and analyzed by one-way ANOVA and Tukey’s post hoc analyses. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Article Snippet: The primary antibodies used were mouse anti-GFAP (1:1000, CST), rabbit anti-GFAP (1:1000, CST), chicken anti-GFAP (1:1000, Abcam), rabbit anti-NeuN (1:500, Abcam), mouse anti-DCX (1:200, Santa Cruz Biotechnology), rabbit anti-Sox2 (1:500, Abcam), mouse anti-Sox2 (1:500, Abcam), rat anti-BrdU (1:1000, Abcam), mouse anti-Tuj1 (1:1000, Abcam), rabbit anti–IIL-13Rα2 (1:500, CST), rabbit anti-CHI3L1 (1:500, Abcam), goat anti-CHI3L1 (1:500, R&D Systems), rabbit anti-CHI3L1 (1:500, Solarbio), rabbit anti-CRTH2 (1:500, Invitrogen), mouse anti-CRTH2 (1:500, Invitrogen), and mouse anti-TMEM219 (1:500, CST).

    Techniques: Expressing, Cell Culture, Activation Assay, Inhibition, shRNA, Injection

    ( A ) Schematic diagram of assays for shRNA-mediated CRTH2 knockdown effect on NSC proliferation and differentiation affected by msAQP4-IgG. The lentiviruses expressing GFP together with a scrambled nontargeting control shRNA (Lenti-shNC) or an shRNA targeting CRTH2 (Lenti-shCRTH2_1). Scale bars, 100 μm. ( B ) CRTH2 knockdown effect on NSC proliferation in DG, quantified by the numbers of proliferating cells expressing an shRNA (GFP + EdU + ) and radial glia–like NSCs (GFP + EdU + GFAP). n = 4 animals. Scale bars, 20 μm. ( C ) Quantification of shRNA-expressing (GFP + ) NSC (BrdU + ) differentiation into immature neurons (DCX + ) in DG. n = 4. Scale bars, 20 μm. ( D ) Quantification of NSC differentiation into mature neurons (GFP + BrdU + NeuN + ) in DG. n = 4. Scale bars, 20 μm. ( E ) Schematic diagram of in vitro assays for the effect of AZD1981, a selective CRTH2 antagonist, on neurogenesis suppressed by CHI3L1 signaling secondary to mini-pump infusion of msCtrl-IgG or msAQP4-IgG. ( F ) Quantification of NSC proliferation in DG, in the presence of CHI3L1 or PBS and with AZD1981 or DMSO. n = 4. Scale bars, 100 μm. ( G ) Quantification of NSC neuronal differentiation. n = 4. Scale bars, 100 μm. ( H ) Schematic diagram of in vivo assays for AZD1981 efficacy to rescue neurogenesis affected by msAQP4-IgG–induced CHI3L1 signaling. ( I and J ) Quantification of NSC proliferation by computing total proliferating cells (EdU + ) and radial glia–like NSCs (EdU + GFAP + Sox2 + ) in DG. n = 4. ( K and L ) Quantification of NSC proliferation into immature (BrdU + DCX + ) and mature (BrdU + NeuN + ) neurons. n = 4 animals. All quantitative data presented as bar graphs in means ± SEM and evaluated by one-way ANOVA and Tukey’s post hoc multiple comparisons. Nonsignificant comparisons are not identified. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Journal: Science Advances

    Article Title: CHI3L1 signaling impairs hippocampal neurogenesis and cognitive function in autoimmune-mediated neuroinflammation

    doi: 10.1126/sciadv.adg8148

    Figure Lengend Snippet: ( A ) Schematic diagram of assays for shRNA-mediated CRTH2 knockdown effect on NSC proliferation and differentiation affected by msAQP4-IgG. The lentiviruses expressing GFP together with a scrambled nontargeting control shRNA (Lenti-shNC) or an shRNA targeting CRTH2 (Lenti-shCRTH2_1). Scale bars, 100 μm. ( B ) CRTH2 knockdown effect on NSC proliferation in DG, quantified by the numbers of proliferating cells expressing an shRNA (GFP + EdU + ) and radial glia–like NSCs (GFP + EdU + GFAP). n = 4 animals. Scale bars, 20 μm. ( C ) Quantification of shRNA-expressing (GFP + ) NSC (BrdU + ) differentiation into immature neurons (DCX + ) in DG. n = 4. Scale bars, 20 μm. ( D ) Quantification of NSC differentiation into mature neurons (GFP + BrdU + NeuN + ) in DG. n = 4. Scale bars, 20 μm. ( E ) Schematic diagram of in vitro assays for the effect of AZD1981, a selective CRTH2 antagonist, on neurogenesis suppressed by CHI3L1 signaling secondary to mini-pump infusion of msCtrl-IgG or msAQP4-IgG. ( F ) Quantification of NSC proliferation in DG, in the presence of CHI3L1 or PBS and with AZD1981 or DMSO. n = 4. Scale bars, 100 μm. ( G ) Quantification of NSC neuronal differentiation. n = 4. Scale bars, 100 μm. ( H ) Schematic diagram of in vivo assays for AZD1981 efficacy to rescue neurogenesis affected by msAQP4-IgG–induced CHI3L1 signaling. ( I and J ) Quantification of NSC proliferation by computing total proliferating cells (EdU + ) and radial glia–like NSCs (EdU + GFAP + Sox2 + ) in DG. n = 4. ( K and L ) Quantification of NSC proliferation into immature (BrdU + DCX + ) and mature (BrdU + NeuN + ) neurons. n = 4 animals. All quantitative data presented as bar graphs in means ± SEM and evaluated by one-way ANOVA and Tukey’s post hoc multiple comparisons. Nonsignificant comparisons are not identified. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Article Snippet: The primary antibodies used were mouse anti-GFAP (1:1000, CST), rabbit anti-GFAP (1:1000, CST), chicken anti-GFAP (1:1000, Abcam), rabbit anti-NeuN (1:500, Abcam), mouse anti-DCX (1:200, Santa Cruz Biotechnology), rabbit anti-Sox2 (1:500, Abcam), mouse anti-Sox2 (1:500, Abcam), rat anti-BrdU (1:1000, Abcam), mouse anti-Tuj1 (1:1000, Abcam), rabbit anti–IIL-13Rα2 (1:500, CST), rabbit anti-CHI3L1 (1:500, Abcam), goat anti-CHI3L1 (1:500, R&D Systems), rabbit anti-CHI3L1 (1:500, Solarbio), rabbit anti-CRTH2 (1:500, Invitrogen), mouse anti-CRTH2 (1:500, Invitrogen), and mouse anti-TMEM219 (1:500, CST).

    Techniques: shRNA, Expressing, In Vitro, In Vivo